Journal DOI 10.68956/journal.human-performance-futures

Creative Commons source reading · Women and female-athlete health

Influence of Estradiol Levels and Menstrual Cycle Phase on Basal and Exercise-Induced ROS and IL-6 Responses in Eumenorrheic Women

Gassner M; Diewald J; Leichtfried L; Zeller L; Ryan S; Wagner KH; König D; König D

Originally published in Sports (Basel) · 2026-04-22

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

AbstractBiological differences between sexes—particularly due to fluctuating levels of 17β-estradiol and menstrual cycle dynamics—may influence exercise-induced reactive oxygen species (ROS) formation, inflammation and exercise performance. Despite these considerations, there is a lack of research exploring how estradiol and menstrual cycle phases may impact exercise performance, exercise-induced ROS formation and inflammation. This study aimed to examine whether estradiol concentration or menstrual cycle phase may be significantly associated with resistance circuit high-intensity interval training (HIIT) performance, as well as exercise-induced formation of ROS and Interleukin-6 (IL-6). A total of 30 young healthy female participants completed a single bout of resistance-based HIIT in a fasted state. Blood samples were collected at…

3.1. Results of Cross-Sectional Study

Results from the cross-sectional part of the study are presented in Table 1. No significant differences were found between estradiol levels (low (11–≤72.5 pg/mL) vs. high (>72.5–394 pg/mL)): −0.038 µmol/min (p = 0.266), menstrual cycle phase (luteal vs. follicular; 0.013 µmol/min (p = 0.716)) and menstruation status (yes vs. no: −0.056 µmol/min (p = 0.259)) for baseline ROS were observed. No significant differences between 17 β-estradiol levels (low vs. high: +0.015 pg/mL (p = 0.906)) for baseline IL-6 concentrations were observed.

3.2. Results Intervention Day (n = 30)

The changes in ROS and IL-6 levels from baseline to 15-post-HIIT are presented in Table 2 and Table 3. No significant differences between estradiol concentrations (ROS: p = 0.477; IL-6: p = 0.249), menstrual cycle phase (ROS; p = 0.752; IL-6: p = 0.557) or menstruation status (ROS: p = 0.383; IL-6: p = 0.808) with baseline, pre-HIIT, post-HIIT or 15-post-HIIT ROS and IL-6 levels were observed. The relationship between menstrual cycle phase, menstruation status, estradiol level and exercise performance is presented in Table 4.

Editorial reading guide

  • Was the study designed for the population to which its conclusion is applied?
  • What safeguard, access need or equity consequence should shape implementation?